ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,731Medicare Part D Prescriptions Filled, Including Refills

Rank: 406 out of 2429

$411K Total Retail Price of All Prescriptions

Rank: 420 out of 2429

258 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 258 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

19% of this provider’s 258 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 5,692 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LEVOTHYROXINE SODIUM 307 238 1 3
LISINOPRIL 300 249 2 2
SIMVASTATIN 255 207 3 1
HYDROCODONE-ACETAMINOPHEN 246 133 S3 4 6
LISINOPRIL-HYDROCHLOROTHIAZIDE 234 163 5 27
METOPROLOL SUCCINATE 225 209 6 12
AMLODIPINE BESYLATE 198 165 7 4
PRAVASTATIN SODIUM 182 141 8 16
WARFARIN SODIUM 155 146 9 11
FUROSEMIDE 154 116 10 5
METFORMIN HCL ER 149 103 11 65
METOPROLOL TARTRATE 143 113 12 9
OMEPRAZOLE 125 99 13 7
HYDROCHLOROTHIAZIDE 111 97 14 10
CARVEDILOL 106 101 15 21
GLIMEPIRIDE 104 89 16 51
NAMENDA 98 74 17 35
ATORVASTATIN CALCIUM 96 78 18 13
METFORMIN HCL 92 79 19 8
SERTRALINE HCL 90 34 20 23
CLOPIDOGREL 78 58 21 31
VENLAFAXINE HCL ER 74 38 22 98
DONEPEZIL HCL 72 60 23 26
TRAZODONE HCL 71 68 24 50
TRAMADOL HCL 71 55 24 17
FENOFIBRATE 66 54 26 48
POTASSIUM CHLORIDE 66 66 26 14
FAMOTIDINE 66 0 26 42
NEXIUM 65 53 29 37
NAPROXEN 65 33 29 75
RISPERIDONE 64 16 31 52
CITALOPRAM HBR 61 43 32 19
PANTOPRAZOLE SODIUM 61 49 32 34
FENTANYL 59 59 S2 34 59
PROAIR HFA 58 32 35 41
TAMSULOSIN HCL 56 55 36 29
LOSARTAN POTASSIUM 56 38 36 22
JANUVIA 55 41 38 66
CRESTOR 50 38 39 25
CYCLOBENZAPRINE HCL 50 0 R 39 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 10, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.